Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yichong Liu
Observed name:
Yi-chong Liu
Institution:
Affiliated Hospital of Qingdao University
Observed institution:
Affiliated Hospital of Qingdao University
ORCID:
0000-0002-6423-3706
Observed ORCID:
0000-0002-6423-3706
OpenAlex ID:
A5111285402
Integrating network pharmacology, molecular docking and experimental verification to reveal the mechanism of artesunate in inhibiting choroidal melanoma
2024
·
Qing-yue Ma
, Yi-chong Liu
, et al.
·
Frontiers in Pharmacology
·
16
Artesunate inhibits vasculogenic mimicry in choroidal melanoma through HIF-1 α/ VEGF/PDGF pathway
2024
·
Qing-yue Ma
, Xiao-yan Xu
, et al.
·
Acta Histochemica
·
16
Artesunate attenuates the tumorigenesis of choroidal melanoma via inhibiting EFNA3 through Stat3/Akt signaling pathway
2024
·
Ningning Yao
, Qingyue Ma
, et al.
·
Journal of Cancer Research and Clinical Oncology
·
13
PDF
AURKA promotes angiogenesis in uveal melanoma via activation of the JAK2/STAT3/VEGFA signaling pathway
2025
·
Qingyue Ma
, Haowen Wang
, et al.
·
Cancer Cell International
·
9
Ang-1 promotes tumorigenesis and mediates the anti-cancer effects of Artesunate on Choroidal melanoma via the regulation of Akt/mTOR signaling pathway
2024
·
Ningning Yao
, Qingyue Ma
, et al.
·
Cytokine
·
6
PLEK2: a potential biomarker for metastasis and prognostic evaluation in uveal melanoma
2024
·
Yichong Liu
, Haiyue Wang
, et al.
·
Frontiers in Medicine
·
1
PDF
Show more works
View as search
Works count:
6
Citation count:
61
H-index:
5
I10-index:
3
Year
Topic
Type